Delivery Order V797D60637-HT940826FE032
Award Date 6/1/26
Potential Completion Date 9/30/30
Potential Value $837K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Health Agency issued a $641,516.80 delivery order to Quidelortho Sales Company, LLC on May 1, 2025, for reagents and consumables under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Quidelortho is a HUBZone-certified joint venture.</p> <p>Place of performance is Fort Belvoir, VA. The order runs through April 30, 2030, and is priced firm fixed price with no set-aside applied.</p>
- The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on September 24, 2022, with a ceiling value of $294,037.83 for chemistry analyzer and laboratory reagents, under the GSA Critical Analyzers, Laboratory (FSS-66-III) master schedule. Quidelortho Sales Company is a HUBZone joint venture based in San Diego, California. Place of performance is Raritan, NJ. The order carries firm fixed pricing and an ultimate completion date of June 30, 2026. No set-aside was used for...
- The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on February 23, 2022, with a ceiling value of $596,855.85 for immunoassay and chemical analyzer equipment and reagents, with ultimate completion scheduled for February 22, 2027. The order was issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Quidelortho Sales Company is a HUBZone joint venture based in San Diego, California, specializing in medical diagnostic equipment and laboratory...
- The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on October 1, 2024, with a ceiling value of $460,280.58 for reagents and basic care maintenance supplies, with completion scheduled for September 30, 2027. This order is issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Quidelortho Sales Company, LLC is a HUBZone-certified joint venture based in San Diego, California, specializing in medical diagnostic equipment, laboratory analyzers,...
- The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on September 3, 2024, with a ceiling value of $341,936.22 for Ortho Clinical Analyzer supplies, reagents, and maintenance on a firm fixed-price basis. The order was issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule framework. Place of performance is Raritan, NJ. The order is scheduled for ultimate completion on October 30, 2025. Quidelortho Sales Company, LLC is a HUBZone joint venture...
- The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, on March 26, 2024, with a ceiling value of $184,561.99 for cost-per-test reagents, equipment, and chemistry analyzer services. The order is issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Place of performance is Raritan, NJ. The order has an ultimate completion date of September 30, 2026. Work involves supply and service of diagnostic testing reagents...
- <p>The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, on October 1, 2026, with a ceiling value of $369,305.64 for the lease of an immunochemistry analyzer and clinical chemistry analyzer under the GSA Critical Analyzers, Laboratory schedule. Performance is in San Diego, CA, with an ultimate completion date of September 30, 2030. The order is priced on a firm fixed-price basis.</p>
- The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on October 1, 2020, with a ceiling value of $153,335.80 under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule for microbiology identification cards and antimicrobial susceptibility testing analyzer and reagents. Place of performance is Raritan, New Jersey. The order carries a firm fixed-price structure and ultimate completion date of September 30, 2025. Quidelortho is a HUBZone joint venture.
- The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, on May 20, 2024, under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule for transfusion medicine testing service and Ortho Clinical Diagnostic reagents for laboratory services, with a ceiling value of $1,206,451.41. Place of performance is Bethesda, MD 20889. The order carries a firm fixed price and an ultimate completion date of May 19, 2029. No set-aside was...
- The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on October 7, 2023, with a ceiling value of $1,174,142.28 under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule for two VITROS XT7600 chemistry analyzers, cost-per-reportable test pricing, and annual service and maintenance including consumables. Quidelortho is a HUBZone joint venture. Place of performance is San Diego, CA 92121. The order extends through October 6, 2028. Pricing is firm fixed...